Citation Impact
Citing Papers
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
2016
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
2015
Chromosome Abnormalities and Genetic Counseling
2011
Hypertension in children with chronic kidney disease: pathophysiology and management
2007
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Doxorubicin pathways
2010 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Dexrazoxane
1998
The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia
2004
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Non-alcoholic fatty liver disease
2021 Standout
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
2018
Cardiovascular Risk Reduction in High-Risk Pediatric Patients
2006
Oxidative stress in chronic kidney disease
2018 Standout
Evidence-based guidelines for the management of hypertension in children with chronic kidney disease
2015
Effects of antihypertensive drugs on blood pressure and proteinuria in childhood
2007
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Health Supervision for Children With Down Syndrome
2011 Standout
Down syndrome
2020 Standout
22q11.2 deletion syndrome
2015 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert�panel�review
2004
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Elastic properties of chiral, anti-chiral, and hierarchical honeycombs: A simple energy-based approach
2016
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Advances in the Understanding of the Genetic Determinants of Congenital Heart Disease and Their Impact on Clinical Outcomes
2018
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
2017
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Auxetic mechanical metamaterials
2017 Standout
Whole-Genome Sequencing and Integrative Genomic Analysis Approach on Two 22q11.2 Deletion Syndrome Family Trios for Genotype to Phenotype Correlations
2015
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective
2021
Works of Paolo Versacci being referenced
Shells and heart: Are human laterality and chirality of snails controlled by the same maternal genes?
2010
A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
2015
3q29 microdeletion: A mental retardation disorder unassociated with a recognizable phenotype in two mother–daughter pairs
2009
Use of ICRF-187 for Prevention of Anthracycline Cardiotoxicity in Children: Preliminary Results
1997
Abnormal Vasomotor Function of the Epicardial Coronary Arteries in Children Five to Eight Years After Arterial Switch Operation
2005
New mutations inZFPM2/FOG2gene in tetralogy of Fallot and double outlet right ventricle
2010
Prevalence and Clinical Significance of Cardiovascular Abnormalities in Patients With the LEOPARD Syndrome
2007
Renal and Cardiovascular Effects of Angiotensin-Converting Enzyme Inhibitor Plus Angiotensin II Receptor Antagonist Therapy in Children With Proteinuria
2006
Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis
2015
Syndromic non‐compaction of the left ventricle: associated chromosomal anomalies
2012
Clinical and functional characterization of a novel RASopathy‐causingSHOC2mutation associated with prenatal‐onset hypertrophic cardiomyopathy
2019